The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias

Main Article Content

Vincenzo De Sanctis
Ashraf Soliman
Ploutarchos Tzoulis
Shahina Daar
Antonis Kattamis
Polyxeni Delaporta
Mohamed A. Yassin
Mehran Karimi
Duran Canatan
Soad Al Jaouni
Maria Concetta Galati
Giuseppe Raiola
Giuseppe Messina
Saveria Campisi
Forough Saki
Dulani Kottahachchi
Valeria Kaleva
Kristina Petrova
Atanas Banchev
Christos Kattamis


Thalassemias, prevalence, glucose dysregulations




Download data is not yet available.
Abstract 397 | PDF Downloads 210


1. De Sanctis V, Soliman A,Tzoulis P, et al. Early detection of glucose dysregulation (GD) in patients with β-thalassemia major: Review of current diagnostic criteria and the ICET-A survey. Curr Trends Endocrinol. 2021;11:1-11.

2. He LN, Chen W, Yang Y, et al. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis. Biomed Res Int 2019;2019:6573497.

3. Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with b-thalassaemia major. Br J Hematol. 2006;134:438-444.

4. Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014;31:583-96.

5. De Sanctis V, Soliman AT. ICET-A an Opportunity for Improving Thalassemia Management. J Blood Disord. 2014;1: 1-2.

6. Chuncharunee S, Teawtrakul N, Siritanaratkul N, Chueamuangphan N. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand. PLoS One 2019;14:e0214148.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 > >>